These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 16955069)

  • 1. Targeting proteases: successes, failures and future prospects.
    Turk B
    Nat Rev Drug Discov; 2006 Sep; 5(9):785-99. PubMed ID: 16955069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease signalling in cell death: caspases versus cysteine cathepsins.
    Turk B; Stoka V
    FEBS Lett; 2007 Jun; 581(15):2761-7. PubMed ID: 17544407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic protease inhibitors as novel therapeutic agents.
    Scott CJ; Taggart CC
    Biochimie; 2010 Nov; 92(11):1681-8. PubMed ID: 20346385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease proteomics: revealing protease in vivo functions using systems biology approaches.
    Doucet A; Overall CM
    Mol Aspects Med; 2008 Oct; 29(5):339-58. PubMed ID: 18571712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of nonpeptide, peptidomimetic peptidase inhibitors that target alternate enzyme active site conformations.
    Rich DH; Bursavich MG; Estiarte MA
    Biopolymers; 2002; 66(2):115-25. PubMed ID: 12325161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Looking at the proteases from a simple perspective.
    Castro HC; Abreu PA; Geraldo RB; Martins RC; dos Santos R; Loureiro NI; Cabral LM; Rodrigues CR
    J Mol Recognit; 2011; 24(2):165-81. PubMed ID: 21360607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity-based fingerprinting of proteases.
    Srinivasan R; Huang X; Ng SL; Yao SQ
    Chembiochem; 2006 Jan; 7(1):32-6. PubMed ID: 16317790
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel therapeutic target in various lung diseases: airway proteases and protease-activated receptors.
    Sokolova E; Reiser G
    Pharmacol Ther; 2007 Jul; 115(1):70-83. PubMed ID: 17532472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
    Tsantrizos YS
    Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors.
    Powers MV; Workman P
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S125-35. PubMed ID: 17259553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular proteases as targets for treatment of cancer metastases.
    Lee M; Fridman R; Mobashery S
    Chem Soc Rev; 2004 Sep; 33(7):401-9. PubMed ID: 15354221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cystatins, thyropins and inhibitors homologous to propeptides of cysteine proteases].
    Gawlik K; Poreba W; Gutowicz J
    Postepy Biochem; 2005; 51(3):318-27. PubMed ID: 16381176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric regulation of proteases.
    Hauske P; Ottmann C; Meltzer M; Ehrmann M; Kaiser M
    Chembiochem; 2008 Dec; 9(18):2920-8. PubMed ID: 19021141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Roles of Protease Inhibitors in Cancer Progression.
    Yang P; Li ZY; Li HQ
    Asian Pac J Cancer Prev; 2015; 16(18):8047-52. PubMed ID: 26745037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docking of noncompetitive inhibitors into dengue virus type 2 protease: understanding the interactions with allosteric binding sites.
    Othman R; Kiat TS; Khalid N; Yusof R; Newhouse EI; Newhouse JS; Alam M; Rahman NA
    J Chem Inf Model; 2008 Aug; 48(8):1582-91. PubMed ID: 18656912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [VI Symposium on "Chemistry of Proteolytic Enzymes"].
    Rumsh LD; Rotanova TV
    Bioorg Khim; 2008; 34(3):293-4. PubMed ID: 18672674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibitors and proteolytic signalling cascades in insects.
    Gubb D; Sanz-Parra A; Barcena L; Troxler L; Fullaondo A
    Biochimie; 2010 Dec; 92(12):1749-59. PubMed ID: 20850496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genomic view of the complexity of mammalian proteolytic systems.
    Puente XS; Sánchez LM; Gutiérrez-Fernández A; Velasco G; López-Otín C
    Biochem Soc Trans; 2005 Apr; 33(Pt 2):331-4. PubMed ID: 15787599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteases and Their Modulators in Cancer Therapy: Challenges and Opportunities.
    Song R; Qiao W; He J; Huang J; Luo Y; Yang T
    J Med Chem; 2021 Mar; 64(6):2851-2877. PubMed ID: 33656892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.